$ALX

WIGHT RUSSELL B JR sold $113K of ALX (indirect holdings)

WIGHT RUSSELL B JR sold 423 indirectly-held shares of ALEXANDERS INC (ALX) at $267.00 ($0.11M total) on 2026-06-09.

Original reporting
SEC EDGAR · WIGHT RUSSELL B JR
Published Jun 10, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 10, 2026, 8:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ALX
Neutral
high confidence
Mentioned
$ALX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALXNeutralLow
01

Why it matters

Provides a concrete, date-stamped insider sale price and share count, which may influence short-term sentiment but does not introduce new company fundamentals.

02

Market read

Traders may monitor insider activity for sentiment, but this specific disclosure is unlikely to drive a major repricing without accompanying fundamental news.

03

What to watch

Consider whether the insider’s remaining holdings (900 shares after sale) and prior transaction history suggest routine diversification rather than a directional view.

Relevance 4/10Novelty 6/10Timing: Filed 2026-06-10 (covers sale dated 2026-06-09)

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Alexanders Inc (ALX).

Company-level read

Ticker impact

$ALXNeutralHigh confidence
Context

SEC Form 4 shows director/10% owner Wight Russell B Jr sold 423 shares of Alexanders Inc at $267/share on 2026-06-09.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider open-market sale with no stated new corporate event (no buyback, guidance, or enforcement action).

Market effects

No clear sector read-through from a single insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales can be planned for liquidity/tax needs; the article notes no pre-arranged 10b5-1 plan, but that still doesn’t imply negative fundamentals by itself.

Key entities

  • ALEXANDERS INC

    Company whose insider transaction is disclosed on Form 4.

  • WIGHT RUSSELL B JR

    Director and 10% owner who sold 423 shares on 2026-06-09.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ALXMedAI 8/10

A $148M Sale Masks What Alexander’s (ALX) Really Earned

Alexander’s Inc. (ALX) reported Q2 net income of $155.4M, up 25x YoY, driven by a $148M gain from selling one property. FFO rose to $15.5M, and revenue increased to $54.7M. However, H1 2026 FFO declined to $28.9M, while revenue edged up to $108.1M. Hedge fund interest grew, but short interest remains high at 13.73%.

$ALXMed

Cebu shipping firm files for IPO

Aznar Shipping Corp. filed for an IPO of up to 1 billion primary shares at P0.67 each, potentially raising P670 million. The company may also offer 100 million secondary shares, adding P67 million if fully exercised. Proceeds will fund fleet expansion and other capital expenditures. The IPO is scheduled for December 2026 on the Philippine Stock Exchange under the ticker ALX.

$ALXMed

Are Atlas Arteria Shares Overvalued? The Street View

Atlas Arteria (ASX: ALX) shares are up 4.72% YTD and trade around A$5.10, with a ~7% dividend yield. RBC Capital Markets downgraded the stock to Underperform and set a A$4.75 price target, citing liquidity concerns as IFM Investors’ hostile bid nears 40–45% and risks to distribution sustainability. IFM’s offer is A$4.75, rising to A$5.10 at 45% ownership.

$ALXMedAI 9/10

Alexander’s Completes Sale of Rego Park I

Alexander’s, Inc. (NYSE: ALX) said it completed the sale of its Rego Park I property in Queens, New York, to Northwell Health. The gross price was $235.5 million and net proceeds were $203 million; it received $224 million at closing after paying $21 million of costs. The company expects a ~$148 million financial statement gain in Q2 and ~$145 million tax gain, with $48 million in 2025 and ~$97 million in 2026.